SI-BONE's iFuse Device Implanted in 25k Patients Worldwide
San Jose, Calif.-based SI-BONE announced more than 8,500 patients have been treated with its iFuse minimally invasive implant system for fusion of the sacroiliac joint. To date, more than 25,000 iFuse implants have been placed in patients worldwide. The device has a triangular-shaped profile that is coated with a porous titanium plasma spray, which allows for biological fixation.
SI-BONE estimates the iFuse Implant System accounts for nearly 90 percent of all minimally invasive SI joint fusion procedures performed in the U.S.
More Articles on Supply Chain:
NuVasive Spine Foundation Raises $230k for Improving Care of Global Patients in Need
Titan Spine Debuts Study Supporting its Device Surface Technology
Medical Device Company DFINE Names Greg Barrett as President, CEO
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New from Becker's ASC Review
How can device programs evolve to meet specific ASC instrumentation needs?Read Now
- Preliminary HCA Q3 results, Tenet stock report & more – 5 recent ASC company key notes
- How can anesthesiologists ensure correct recording of anesthesia start time?
- 5 spine, orthopedic devices for ASCs
- How can device programs evolve to meet specific ASC instrumentation needs?
- Sunshine Act database gets an overhaul